Concepedia

Kate Lynn J. Bill

KL

Statistics

Publications

7

Citations

467

H-Index

7

Active since

2015

Affiliations

The Ohio State University(Current)

Sheba Medical Center

The University of Texas MD Anderson Cancer Center

Cancer Genetics (United States)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Kate Lynn J. Bill is an author at The Ohio State University specializing in medicine, oncology, and molecular oncology.

Publications per year

2015–2019

7

Publications

7

Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression

Lucia Casadei, Federica Calore, Chad J. Creighton et al. · Cancer Research · 2017 · 199 citations · Full text

, , +17

SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

Kate Lynn J. Bill, Jeannine Garnett, Isabelle Meaux et al. · Clinical Cancer Research · 2015 · 106 citations · Full text

, , +14

HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)

Gonzalo Lopez, Kate Lynn J. Bill, Hemant K. Bid et al. · PLoS ONE · 2015 · 59 citations · Full text

, , +13

Degree of <i>MDM2</i> Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma

Kate Lynn J. Bill, Nathan D. Seligson, John L. Hays et al. · The Oncologist · 2019 · 42 citations · Full text

, , +17

HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components

Gonzalo Lopez, Yechun Song, Ryan Lam et al. · Molecular Cancer Research · 2015 · 30 citations · Full text

, , +16

1–5 of 7